CNS pipeline · person
Susan Altschuller, PhD, MBA
Chief Financial Officer of Cerevel Therapeutics, appointed effective May 15, 2023 (succeeding interim CFO Mark Bodenrader). Previously Chief Financial Officer of ImmunoGen.
- 1 company
Courtesy Cerevel Therapeutics
Current roles
- Cerevel TherapeuticsChief Financial Officer · Executive2023–present
Appears with
People sharing a company with Susan.
- Adam Koppel · Cerevel Therapeutics
- Christopher Gordon · Cerevel Therapeutics
- Deborah Baron · Cerevel Therapeutics
- Deval Patrick · Cerevel Therapeutics
- Doug Giordano · Cerevel Therapeutics
- Gabrielle Sulzberger · Cerevel Therapeutics
- John Renger · Cerevel Therapeutics
- Kathleen Tregoning · Cerevel Therapeutics
- Kenneth DiPietro · Cerevel Therapeutics
- Marijn Dekkers · Cerevel Therapeutics
- Mark Bodenrader · Cerevel Therapeutics
- N. Anthony Coles · Cerevel Therapeutics
- Norbert G. Riedel · Cerevel Therapeutics
- Paul Burgess · Cerevel Therapeutics
- Raymond Sanchez · Cerevel Therapeutics
- Ron Renaud · Cerevel Therapeutics
- Ruth McKernan · Cerevel Therapeutics
- Scott Akamine · Cerevel Therapeutics
- Suneet Varma · Cerevel Therapeutics
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.